# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-077655
Filing Date
2020-06-29
Accepted
2020-06-29 06:30:23
Documents
9
Period of Report
2020-08-04
Effectiveness Date
2020-06-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2023357-1_def14a.htm | DEF 14A | 1397282
2 | GRAPHIC | sg_ronaldlombardi-bw.jpg | GRAPHIC | 1223826
3 | GRAPHIC | sg_williamcpooi-bw.jpg | GRAPHIC | 41835
4 | GRAPHIC | tm2023357d1-bc_netgaapbw.jpg | GRAPHIC | 960719
5 | GRAPHIC | tm2023357d1-bc_ceobw.jpg | GRAPHIC | 778957
6 | GRAPHIC | tm2023357d1-pc_ceoneobw.jpg | GRAPHIC | 941764
7 | GRAPHIC | tm2023357d1-px_signbw.jpg | GRAPHIC | 691203
8 | GRAPHIC | tm2023357d1-px_votingbw.jpg | GRAPHIC | 772699
9 | GRAPHIC | tm2023357d1-px_annualbw.jpg | GRAPHIC | 1470561
| Complete submission text file | 0001104659-20-077655.txt |  | 10792475

Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Consumer Healthcare Inc. (Filer) CIK: 0001295947 (see all company filings)

EIN.: 201297589 | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-32433 | Film No.: 20995874
SIC: 2834 Pharmaceutical Preparations